Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine for Post-Cataract Corneal Edema
NCT00800423Phase 3Unknown
- Sponsor
- Rabin Medical Center
- Start
- Jan 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of brimonidine in corneal edema (3 arms), sponsored by Rabin Medical Center. Primary endpoint: Central Corneal Thickness at Day 30. Status: unknown.
02
Drugs
brimonidine
03
Conditions
corneal edema
Beyond the preview
Go deeper on NCT00800423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00800423.